Thomas R. Staab II

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Durham, NC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas R. Staab II

Form 4 holding Chief Financial Officer

LENSAR, Inc.

Security class
Common Stock
Shares / value
174,609
Estimated value
$1,040,669
Report date
06 May 2026
Price
$5.96
Ownership
Direct
Form 4 holding Chief Financial Officer

TENAX THERAPEUTICS, INC.

Security class
Stock Option (right to buy)
Shares / value
450,000
Estimated value
Report date
11 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

LENSAR, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
14,295
Estimated value
Report date
19 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas R. Staab II

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .